4-(2-FLUORO-4-NITROPHENYL)THIOMORPHOLINE, 95.0%, 5g

O-Acetyl-D-serine hydrochloride, 98.0%, 1g

2-Methyladamantan-2-yl Acrylate (stabilized with MEHQ)>98.0%(GC)25g

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

9-[(2S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one, 98.0%, 1kg

6-Bromo-2-methylaminopyridine, 98%, 1g

4-BROMO-7-METHOXY-1-METHYL-1H-PYRROLO[2,3-C]PYRIDINE, 95%, 100mg

Imidazo[1,2-b]pyridazine-6-carboxylic acid, 95.0%, 250mg

Methyl 4-(4-fluorophenyl)-4-oxobutyrate, 95.0%, 10g

2-(4-Methoxyphenyl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole, 97.0%, 5g

1,3,4,6-Tetrathiapentalene-2,5-dione, 98.0%, 1g

4-Chloro-2-(trifluoromethyl)phenol, 95.0%, 5g

2-Chloro-8-methyl-7,8-dihydropteridin-6(5H)-one, 95%, 250mg